Nitromethane

Nitromethane

SCHEMBL3012923

C[N+](=O)[O-].Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Nitromethane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitromethane SCHEMBL28102645 1.00
Nitromethane SCHEMBL28020774 0.95
Nitromethane SCHEMBL14686120 0.95
Nitromethane SCHEMBL14686122 0.95
Nitromethane SCHEMBL22685862 0.95
Nitromethane SCHEMBL27366359 0.94
Nitromethane SCHEMBL525 0.94
Nitromethane SCHEMBL29707679 0.94
Nitromethane SCHEMBL1890507 0.89
Nitromethane SCHEMBL8771927 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112034008-A Graphene crystal structure quality evaluation method 电子科技大学 2020-12-04 CN claimed
CN-110627193-A Biofilm reactor treatment device and method for chlorine disinfection byproducts 杭州师范大学 2019-12-31 CN claimed
CN-107574230-A The composition and method for the hybridization being individually denatured for carrying out sample and probe 丹麦达科有限公司 2018-01-12 CN claimed
CN-102369295-A Compositions and methods for performing hybridization with separate denaturation of sample and probe DAKO DENMARK AS 2012-03-07 CN claimed
CN-102084004-A Hybridization compositions and methods DAKO DENMARK AS 2011-06-01 CN claimed
CN-102046808-A Compositions and methods for detecting chromosomal aberrations using novel hybridization buffers DAKO DENMARK AS 2011-05-04 CN claimed
CN-117720559-A Keggin type polyacid-based Cu (II) coordination ion crystal and preparation method thereof 北京化工大学 2024-03-19 CN disclosed
CN-117069576-A Method for synthesizing calcium formate by direct oxidation of methanol 浙江工业大学 2023-11-17 CN disclosed
CN-109641068-B Method and device for preparing ultrasonic contrast agent 蓝瑟斯医学影像公司 2022-09-30 CN disclosed
CN-112034008-A Graphene crystal structure quality evaluation method 电子科技大学 2020-12-04 CN disclosed
CN-107574230-A The composition and method for the hybridization being individually denatured for carrying out sample and probe 丹麦达科有限公司 2018-01-12 CN disclosed
CN-102369295-B Compositions and methods for performing hybridization with separate denaturation of sample and probe 丹麦达科有限公司 2017-11-24 CN disclosed
CN-107254513-A It is used for the composition and method for detecting chromosome aberration using new hybridization buffer 丹麦达科有限公司 2017-10-17 CN disclosed
CN-102046808-A Compositions and methods for detecting chromosomal aberrations using novel hybridization buffers DAKO DENMARK AS 2011-05-04 CN disclosed
US-20100204470-A1 METHOD FOR SALT PREPARATION SANDOZ AG 2010-08-12 US disclosed
EP-2145890-A2 Crystallization of hydrohalides of pharmaceutical compounds Sandoz AG (CH) 2010-01-20 EP disclosed
EP-2032521-B1 NEW METHOD FOR SALT PREPARATION SANDOZ AG (CH) 2009-10-28 EP disclosed
EP-2032521-A2 NEW METHOD FOR SALT PREPARATION Sandoz AG (CH) 2009-03-11 EP disclosed
WO-2008000418-A2 NEW METHOD FOR SALT PREPARATION SANDOZ AG (CH) 2008-01-03 WO disclosed
US-5449582-A Pigment-Lewis acid complex XEROX CORPORATION (US) 1995-09-12 US disclosed